MedPath
HSA Approval

TERRAMYCIN OPHTHALMIC OINTMENT

SIN09695P

TERRAMYCIN OPHTHALMIC OINTMENT

TERRAMYCIN OPHTHALMIC OINTMENT

April 6, 1998

PFIZER PRIVATE LIMITED

PFIZER PRIVATE LIMITED

Regulatory Information

PFIZER PRIVATE LIMITED

PFIZER PRIVATE LIMITED

Therapeutic

Prescription Only

Formulation Information

OINTMENT

4.2 Posology and Method of Administration Oxytetracycline with Polymyxin B ophthalmic preparations are administered as a small quantity (approximately 1 cm) of the ointment. The preparation should be instilled or applied into the conjunctival sac of the lower lid 4 to 6 times daily until the infection is cleared and healing is complete. This may take from one day to several weeks depending on the nature and severity of the infection. In blepharitis, scales and crusts should be removed before applying medication. For prophylaxis, the same procedure is followed on the day before the operation and subsequently for several days following it. The patient should be instructed to avoid contamination of the tip of the tube when applying the ointment.

OPHTHALMIC

Medical Information

4.1 Therapeutic indications Oxytetracycline with Polymyxin B Ophthalmic preparations are indicated in the treatment of superficial ocular infections involving the conjunctiva and/or cornea due to susceptible microorganisms.

4.3 Contraindications These products are contraindicated in persons who have shown hypersensitivity to any of their components.

S01AA30

combinations of different antibiotics

Manufacturer Information

PFIZER PRIVATE LIMITED

PT PFIZER INDONESIA

Active Ingredients

POLYMYXIN B SULPHATE EQV POLYMYXIN B

10000 iu/g

Polymyxin B

OXYTETRACYCLINE HCl EQV OXYTETRACYCLINE

5 mg/g

Oxytetracycline

Documents

Package Inserts

terramycin Opthalmic Oint PI.pdf

Approved: March 14, 2012

Download
© Copyright 2025. All Rights Reserved by MedPath